AI assistant
Sending…
Anterix Inc. — Director's Dealing 2021
Feb 20, 2021
33018_dirs_2021-02-19_069a1293-57ba-4f46-8170-d7243b254945.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2021-02-18
Reporting Person: Guttman-McCabe Christopher (Chief Reg & Comm Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-18 | Common Stock | S | 7538 | $44.255 | Disposed | 36482 | Direct |
Footnotes
F1: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $44.01 to $44.63. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
More from Anterix Inc.
Fund Information / Factsheet
2026
Apr 21
Regulatory Filings
2026
Apr 21
Capital/Financing Update
2026
Apr 6
Regulatory Filings
2026
Apr 1
Earnings Release
2026
Feb 11
Interim / Quarterly Report
2026
Feb 11
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 30
Board/Management Information
2026
Jan 7
Director's Dealing
2025
Dec 19